IDYA - IDEAYA Biosciences, Inc.

QQQ $ 450.22 $ 2.34 (0.52 %)

DIA $ 395.16 $ 0.63 (0.16 %)

SPY $ 532.81 $ 2.34 (0.44 %)

TLT $ 96.28 $ 0.94 (0.99 %)

GLD $ 224.54 $ 0.55 (0.25 %)

Previous Close

$ 37.89

Open

Bid

$ 37.89 x 200

Ask

$ 37.95 x 200

Day's Range

-- - --

52 Week Range

$ 23.41 - $ 47.74

Volume

560,125

Average Volume

Market Cap

2.95B

Beta (5Y Monthly)

$ 0.90

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-07-2024	03-31-2024	10-Q
3	02-20-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	03-07-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-15-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-17-2022	12-31-2021	10-K
12	11-15-2021	09-30-2021	10-Q
13	08-10-2021	06-30-2021	10-Q
14	05-10-2021	03-31-2021	10-Q
15	03-23-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	08-12-2020	06-30-2020	10-Q
18	05-12-2020	03-31-2020	10-Q
19	03-24-2020	12-31-2019	10-K
20	11-13-2019	09-30-2019	10-Q
21	08-12-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

JP Morgan Maintains Overweight on IDEAYA B...
08/08/2024 16:15:19

JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight and lowers the price target from ...

RBC Capital Reiterates Outperform on IDEAY...
08/07/2024 16:33:43

RBC Capital analyst Gregory Renza reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $61 price target.

Wedbush Reiterates Outperform on IDEAYA Bi...
08/07/2024 14:32:10

Wedbush analyst Robert Driscoll reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $54 price target.

Oppenheimer Maintains Outperform on IDEAYA...
08/07/2024 11:51:57

Oppenheimer analyst Matthew Biegler maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and lowers the price target...

IDEAYA Biosciences Cash, Cash Equivalents ...
08/06/2024 10:06:52

IDEAYA Biosciences Q2 2024 GAAP EPS $(0.68...
08/06/2024 10:05:33

IDEAYA Biosciences Announced That It Has E...
07/31/2024 10:04:15

JP Morgan Maintains Overweight on IDEAYA B...
07/12/2024 15:06:11

JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight and raises the price target from ...

RBC Capital Maintains Outperform on IDEAYA...
07/11/2024 14:53:04

RBC Capital analyst Gregory Renza maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target f...

why-seastar-medical-holding-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why SeaStar Medical Holding Shares Are Tra...
07/10/2024 17:18:59

kura-sushi-posts-weak-q3-results-joins-legalzoomcom-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Kura Sushi Posts Weak Q3 Results, Joins Le...
07/10/2024 12:01:12

Reported Earlier, IDEAYA Prices $263M Publ...
07/10/2024 06:32:51

IDEAYA is selling 7,228,572 shares of common stock and pre-funded warrants to purchase 285,715 shares of common stock in the ...

IDEAYA Biosciences Intends To Offer Up To ...
07/09/2024 20:10:50

BTIG Maintains Buy on IDEAYA Biosciences, ...
07/09/2024 16:36:09

BTIG analyst Justin Zelin maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and raises the price target from $55 to $62.

Stifel Maintains Buy on IDEAYA Biosciences...
07/08/2024 17:54:31

Stifel analyst Benjamin Burnett maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and maintains $63 price target.

Oppenheimer Maintains Outperform on IDEAYA...
07/08/2024 17:52:01

Oppenheimer analyst Matthew Biegler maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target...

why-arhaus-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Arhaus Shares Are Trading Lower By Aro...
07/08/2024 17:16:55

IDEAYA Biosciences Highlights 'Encouraging...
07/08/2024 16:31:14

IDEAYA Biosciences reports promising Phase 2 clinical data for IDE397 in MTAP-deletion urothelial and NSCLC patients. The study...

corning-increases-sales-forecast-joins-morphic-holding-lucid-group-and-other-big-stocks-moving-higher-on-monday

Corning Increases Sales Forecast, Joins Mo...
07/08/2024 14:19:23

Mizuho Initiates Coverage On IDEAYA Biosci...
07/08/2024 11:11:23

Mizuho analyst Graig Suvannavejh initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform rating and announc...